OverviewChartNewsTraderScreen

REGEN III CORP/  CA75888V1004  /

TSX Venture Exchange
5/21/2024  9:20:08 PM Chg. -0.025 Volume Bid10:00:11 PM Ask10:00:11 PM High Low
0.325CAD -7.14% 58,500
Turnover: 19,340		 0.320Bid Size: 20,500 0.330Ask Size: 10,000 0.350 0.325
GlobeNewswire 5/15 Circe Bioscience licenses technology to decarbonize industry with microbes developed at Wyss Institu...
GlobeNewswire 5/10 ProKidney Reports Business Updates and First Quarter 2024 Financial Results
GlobeNewswire 5/8 Presenting on the Emerging Growth Conference 70 Day 2 on May 9 Register Now
GlobeNewswire 5/7 Presenting on the Emerging Growth Conference 70 Day 1 on May 8 Register Now
Newsfile Corp 5/2 ReGen III Invited to Present at the Emerging Growth Conference
Newsfile Corp 4/30 ReGen III Announces Convertible Debenture Offering
Newsfile Corp 4/16 ReGen III Provides Update on Pilot Testing, Offtake Negotiations, LPO Application, Greenhouse Gas Cr...
GlobeNewswire 4/3 Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
GlobeNewswire 4/2 Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now
GlobeNewswire 3/22 ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
GlobeNewswire 3/6 Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
GlobeNewswire 3/5 Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now
Newsfile Corp 3/4 ReGen III Submits Part I Application to the U.S. Department of Energy's Loan Programs Office
GlobeNewswire 2/28 PickleJar Announces Sponsorship With CRS 2024 Including Multiple Activations
Newsfile Corp 2/26 ReGen III Commences Additional Pilot Study with KMPS and Engages ICP Securities Inc. for Automated M...
GlobeNewswire 2/6 Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now
GlobeNewswire 2/2 Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
GlobeNewswire 1/25 Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year an...
GlobeNewswire 1/10 Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream
GlobeNewswire 1/9 Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now
Newsfile Corp 12/20/2023 ReGen III Provides Intellectual Property and Funding Update
GlobeNewswire 12/7/2023 BioAdaptives Announces Special Holiday Wellness Offers and Gift
GlobeNewswire 12/7/2023 Regeneron to Share Progress of Novel Combination Therapies in Oncology at ESMO IO
GlobeNewswire 12/6/2023 Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now
GlobeNewswire 12/5/2023 Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now